Aperio Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Aperio Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,542	Closed	-$1.3M	–	2461
2020 Q3	$1.3M	Buy	9,542 +59	+0.6%	+$6.27K	﹤0.01%	1316
2020 Q2	$916K	Buy	9,483 +2,493	+36%	+$208K	﹤0.01%	1455
2020 Q1	$327K	Buy	6,990 +1,620	+30%	+$104K	﹤0.01%	1857
2019 Q4	$392K	Buy	5,370 +1,153	+27%	+$69.9K	﹤0.01%	1937
2019 Q3	$220K	Buy	4,217 +2,382	+130%	+$127K	﹤0.01%	2142
2019 Q2	$92K	Buy	+1,835	New	+$89.3K	﹤0.01%	2406

Aperio Group's MYOK Position: Q4 2020 in Review

Aperio Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 9,542 shares — an estimated $1.3M sold.

Aperio Group first reported a position in MYOK in Q2 2019 and held it in 6 quarters. The position peaked at $1.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Aperio Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Aperio Group sold 9,542 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.3M.
Aperio Group first reported a position in MyoKardia, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
Aperio Group's MyoKardia, Inc. Common Stock position peaked at $1.3M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.